Leandro Safatle
Leandro Safatle is a Brazilian health official and the current director of the National Health Surveillance Agency (Anvisa). He has been in the news recently due to his participation in discussions on health cooperation agreements between Brazil and Mexico, particularly focusing on the development and production of vaccines and therapies.
Not in the pool (under ¢1).
Recent news mentions
Leandro Safatle is the president of Anvisa and affirmed that the Ypê factory meets the necessary conditions to operate safely.
Anvisa autoriza produção em fábrica da Ypê, mas mantém recomendação para não usar produtos já fabricados
Brazil· 2026-05-30Leandro Safatle is the new director-president of Anvisa, focusing on accelerating processes and reducing analysis queues.
'Os fitoterápicos têm um potencial enorme, podem ser uma revolução', diz novo diretor-presidente da AnvisaBrazil· 2025-12-20Leandro Safatle, the director-president of Anvisa, classified the collaboration between the agency, the Ministry of Health, and the productive sector as fundamental for addressing the outbreak of methanol poisoning cases in the country.
Anvisa libera fabricação de 1º lote de etanol farmacêutico, antídoto usado para casos de intoxicaçãoBrazil· 2025-10-12
Leandro Safatle, the director-president of the National Health Surveillance Agency (Anvisa), discusses the provision of antidotes for methanol poisoning.
'A prioridade é fornecer o antídoto de forma rápida', diz presidente da Anvisa em meio à crise do metanolBrazil· 2025-10-05Leandro Safatle is the director-president of Anvisa and explains the agency's resolution to regulate the production of pharmaceutical ethanol as an antidote for methanol contamination.
Anvisa regulamenta produção em larga escala de antídoto contra intoxicação por metanolBrazil· 2025-10-04Leandro Safatle, the President of the National Health Surveillance Agency, was part of Alckmin's delegation.
Alckmin se reúne com Sheinbaum, do México, e diz que o Brasil busca mercados para além do tarifaço
Liechtenstein· 2025-08-29
